Biotech
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 10/11/15 -- BioMmune Technologies Inc. (the "Company") (TSX VENTURE: IMU), announces a non-brokered private placement of up to 2,000,000 uni ...
COLUMBUS, OH: COLUMBUS, OH -- (Marketwired) -- 10/09/15 -- Sermonix Pharmaceuticals LLC, a specialty pharmaceutical company focused on the development and commercialization of emerging late-stage women's heal ...
SEATTLE, WA: SEATTLE, WA -- (Marketwired) -- 10/09/15 -- Atossa Genetics Inc. (NASDAQ: ATOS) a healthcare company focused on improving breast health through the development of pharmaceuticals to treat breast heal ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 10/08/15 -- Medworxx Solutions Inc. (TSX VENTURE: MWX) ("Medworxx"), is pleased to announce that Medworxx shareholders have approved the previously ann ...
CAMBRIDGE, MA: CAMBRIDGE, MA -- (Marketwired) -- 10/08/15 -- Proteostasis Therapeutics, Inc. (PTI), a company developing novel therapeutics to treat diseases caused by defects in protein processing, today announced ...
BERKELEY, CA: BERKELEY, CA -- (Marketwired) -- 10/08/15 -- Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that it has initiated patient dosing in the company's trial evaluating the combinatio ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 10/08/15 -- Titan Pharmaceuticals, Inc. (OTCQB: TTNPD), a specialty pharmaceutical company developing proprietary therapeutics for the treatment of select ...
COLUMBUS, OH: Research on the Company's Investigational Drug, Lasofoxifene, Takes First Place Among Scientific Posters ...
NORWOOD, MA: Corbus Expects to Report Top-Line Phase 2 Data in Systemic Sclerosis at End of 2016 ...
MANCHESTER, NH: Trial to Include Chinese Subjects With Pre-Diabetes ...
LYON, FRANCE: LYON, FRANCE -- (Marketwired) -- 10/05/15 -- Flamel Technologies (NASDAQ: FLML) announced today that the Company's Irish subsidiary, Flamel Ireland Limited, has licensed exclusive U.S. rights to ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 10/05/15 -- Hemostemix Inc. ("Hemostemix" or the "Company") (TSX VENTURE: HEM), a clinical-stage autologous cell-therapy company, announced to ...
DUBLIN, IRELAND: Positive Study Results Support Company's Current Development and Regulatory Efforts for VIBATIV ...
DUBLIN, IRELAND: DUBLIN, IRELAND -- (Marketwired) -- 10/02/15 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") announced today that stock options to purchase ...
MINNEAPOLIS, MN: Healthcare Executive Brings Extensive Public Company Financial Experience to Leadership Team ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwired) -- 10/01/15 -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced its financial results for the third quarter ended August 31, 2015.Third quarter ...
LAVAL, QUEBEC: - ProMetic allowed to proceed with filing of IND for pivotal study ahead of anticipated timelines - PBI-4050 to be added in combination to commercially available drugs in pivotal study ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 09/30/15 -- SciVac Therapeutics Inc. ("SciVac" or the "Company") (TSX: VAC)(OTCQX: SVACF) today announced the results for its Annu ...
